Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits

Joint Bone Spine

Volumn 75, Issue 6, 2008, Pages 696-701

  Pengde, Kang ^a   Fuxing, Pei ^a   Bin, Shen ^a   Jing, Yang ^a   Jingqiu, Cheng ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adipogenesis; Corticosteroid; Lovastatin; Marrow fat cell; Osteonecrosis; Rabbit

Indexed keywords

LIPID; METHYLPREDNISOLONE ACETATE; MEVINOLIN; PLACEBO; SODIUM CHLORIDE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BONE MARROW; BONE NECROSIS; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; FEMUR; HISTOPATHOLOGY; HUMERUS; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; NONHUMAN; RABBIT;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTICHOLESTEREMIC AGENTS; BONE MARROW CELLS; CELL SIZE; DISEASE MODELS, ANIMAL; FEMUR HEAD; FEMUR HEAD NECROSIS; HUMERUS; LIPIDS; LOVASTATIN; MALE; METHYLPREDNISOLONE; OSTEOCYTES; RABBITS;

EID: 57049184083     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.12.008     Document Type: Article

References (22)

1. Wang G.J., Cui Q., and Balian G. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop 370 (2000) 295-310
2. Mont M.A., and Hungerford D.S. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77 (1995) 459-474
3. Miyanishi K., Yamamoto T., Irisa T., et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone 30 (2002) 185-190
4. Jones Jr. J. Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop 292 (1993) 294-308
5. Koo K.H., Dussalt R.G., Kaplan P.A., et al. Fatty marrow conversion of the proximal femoral metaphysic in osteonecrosis hips. Clin Orthop 361 (1999) 159-167
6. Yamamoto T., Hirano K., Tsutsui H., et al. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop 316 (1995) 235-243
7. Li X.D., Cui Q., Kao C.H., et al. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPAR2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33 (2003) 652-659
8. Cui Q., Wang G.J., and Su C.C. The Otto Aufranc award: lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop 344 (1997) 8-19
9. Hirano K., Tsutsui H., Sugioka Y., et al. Histopathologic alterations of retinacular vessels and osteonecrosis. Clin Orthop 324 (1997) 192-204
10. Emmanuele L., Ortmann J., Doerflinger T., et al. Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth. Biochem Biophys Res Commun 302 (2003) 67-72
11. Mundy G., Garrett R., Harris S., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
12. Yamamoto T., Irisa T., Sugioka Y., et al. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 40 (1997) 2055-2064
13. Matsui M., Saito S., and Ohzono K. Experimental steroid-induced osteonecrosis in adult rabbits with hypersensitivity vasculitis. Clin Orthop 277 (1992) 61-72
14. Shaw S.L., Salmon E.D., and Quatrano R.S. Digital photography for the light microscope: results with a gated, video-rate CCD camera and NIH-image software. Biotechniques 19 (1995) 946-955
15. Parfitt A.M., Drezner M.K., and Glorieux F.H. Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 2 (1987) 595-610
16. Lee K., Park S.Y., Lee D.H., et al. Lovastatin increases longitudinal bone growth and bone morphogenetic protein-2 levels in the growth plate of Sprague-Dawley rats. Eur J Pediatr 161 (2002) 406-407
17. Wang G.J., Chung K.C., and Shen W.J. Lipid clearing agents in steroid-induced osteoporosis. J Formos Med Assoc 94 (1995) 589-592
18. Davidson J., Coogan P., and Gunneson E. The asymptomatic contralateral hip in osteonecrosis of the femoral head. In: Unbaniak J., and Jones Jr. J. (Eds). Osteonecrosis: etiology, diagnosis and treatment (1997), American Academy of Orthopaedic Surgeons, Rosemont, IL 231-240
19. Wang G.J. Pathogenesis of steroid-induced avascular necrosis and its response to lipid clearing agents. In: Hirohata K., Mizuno K., and Matsubara T. (Eds). Trends in research and treatment of joint diseases (1992), Springer-Verlag, Tokyo 59-71
20. Motomura G., Yamamoto T., Miyanishi K., et al. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Am Coll Rheumatol 110 (2004) 3387-3391
21. Burkhardt R., Kettner G., and Bohm W. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8 (1987) 157-164
22. Sambrook P.N., and Jones G. Corticosteroid osteoporosis. Br J Rheumatol 34 (1995) 8-12